Option Care Health downgraded by Stephens with a new price target
$OPCH
Medical/Nursing Services
Health Care
Stephens downgraded Option Care Health from Overweight to Equal-Weight and set a new price target of $24.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/17/2026 | $24.00 | Overweight → Equal-Weight | Stephens |
| 6/8/2026 | $22.00 | Neutral | Goldman |
| 5/1/2026 | $22.00 | Buy → Neutral | BofA Securities |
| 12/11/2025 | $40.00 | Overweight | Stephens |
| 10/2/2025 | $30.00 | Hold | TD Cowen |
| 4/30/2025 | $40.00 | Neutral → Buy | UBS |
| 1/23/2025 | $26.00 → $35.00 | Hold → Buy | Jefferies |
| 1/13/2025 | $26.00 → $33.00 | Neutral → Buy | BofA Securities |
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
SCHEDULE 13G/A - Option Care Health, Inc. (0001014739) (Subject)
4 - Option Care Health, Inc. (0001014739) (Issuer)
3 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
BANNOCKBURN, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2026 on Wednesday, July 29, 2026 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI808c970d451b4e5ba580364e7e07d20a. The call can also be accessed via a liv
BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026. In this role, Okunski will lead the Company's investor relations strategy and serve as the primary liaison between Option Care Health and the investment community. He will be responsible for communicating the Company's business strategy, financial performance, capital allocation priorities and long-term growth opportunities to investors, analysts and other key stakeholders. "Bob brings more than two decade
BANNOCKBURN, Ill., June 01, 2026 (GLOBE NEWSWIRE) -- Option Care Health is proud to announce it has been ranked No. 15 on the World's Most Impactful Companies 2026 list, a global recognition of organizations delivering measurable positive impact across society, the environment, and the economy. This recognition is presented by TIME and Statista, global leaders in data analysis and industry benchmarking, and it can now be viewed on time.com. Being named to the World's Most Impactful Companies 2026 list signifies that Option Care Health stands among a select group of organizations driving meaningful change through their core business activities. Unlike perception-based assessments or self-r
Stephens downgraded Option Care Health from Overweight to Equal-Weight and set a new price target of $24.00
Goldman initiated coverage of Option Care Health with a rating of Neutral and set a new price target of $22.00
BofA Securities downgraded Option Care Health from Buy to Neutral and set a new price target of $22.00
BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026. In this role, Okunski will lead the Company's investor relations strategy and serve as the primary liaison between Option Care Health and the investment community. He will be responsible for communicating the Company's business strategy, financial performance, capital allocation priorities and long-term growth opportunities to investors, analysts and other key stakeholders. "Bob brings more than two decade
BANNOCKBURN, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Meenal Sethna as Executive Vice President and Chief Financial Officer, effective October 1, 2025. Sethna will succeed Mike Shapiro, who has decided to step down as CFO effective September 30, 2025, following a decade of service to the Company. At the time of the transition, Shapiro will remain with the Company as a Strategic Advisor through at least the first quarter of 2026 to continue to help advance the Company's strategy and ensure a smooth
Marks major milestone with completion of enrollment in pivotal Phase 3 NEAT clinical trial evaluating lead asset, eDSP, for the treatment of A-T; topline results expected in first quarter of 2026 Closed financing priced at a premium bringing existing cash position to approximately $35 million; expected to provide runway through Phase 3 topline results and into at least second quarter of 2026 Entered into strategic relationship with Option Care Health to support commercial launch of eDSP in the U.S. Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an
BANNOCKBURN, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2026 on Wednesday, July 29, 2026 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI808c970d451b4e5ba580364e7e07d20a. The call can also be accessed via a liv
BANNOCKBURN, Ill., April 30, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights(year-over-year comparisons unless otherwise noted) Net revenue of $1,350.7 million, up 1.3%GAAP Net income of $45.3 million, down 3.0%GAAP diluted earnings per share of $0.29, up 3.6%Adjusted EBITDA of $104.8 million, down 6.3%Adjusted diluted earnings per share of $0.40, flat to the first quarter of 2025Cash used in operating activities of $12.1 million
BANNOCKBURN, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2026 on Thursday, April 30, 2026 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BIbd179b6862b941cc9436001259706de3. The call can also be accessed via a li
SC 13G - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)